South Korea
· Delayed Price · Currency is KRW SunBio,Inc. Statistics
Total Valuation
SunBio,Inc. has a market cap or net worth of KRW 86.07 billion.
| Market Cap | 86.07B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, September 13, 2024.
| Earnings Date | Sep 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SunBio,Inc. has 12.31 million shares outstanding.
| Shares Outstanding | 12.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 32.68% |
| Owned by Institutions (%) | 0.00% |
| Float | 8.25M |
Valuation Ratios
The trailing PE ratio is 28.03.
| PE Ratio | 28.03 |
| Forward PE | n/a |
| PS Ratio | 18.00 |
| PB Ratio | 8.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.81
| Current Ratio | 10.81 |
| Quick Ratio | 10.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 15.38 |
Financial Efficiency
Return on equity (ROE) is 35.40% and return on invested capital (ROIC) is 4.92%.
| Return on Equity (ROE) | 35.40% |
| Return on Assets (ROA) | 4.64% |
| Return on Capital (ROIC) | 4.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 8.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.86% |
| 50-Day Moving Average | 7,296.60 |
| 200-Day Moving Average | 8,532.65 |
| Relative Strength Index (RSI) | 46.73 |
| Average Volume (20 Days) | 33,994 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SunBio,Inc. had revenue of KRW 2.17 billion and earned 1.39 billion in profits. Earnings per share was 249.33.
| Revenue | 2.17B |
| Gross Profit | 1.23B |
| Operating Income | 349.26M |
| Pretax Income | 1.50B |
| Net Income | 1.39B |
| EBITDA | 403.98M |
| EBIT | 349.26M |
| Earnings Per Share (EPS) | 249.33 |
Balance Sheet
| Cash & Cash Equivalents | 3.48B |
| Total Debt | n/a |
| Net Cash | 3.48B |
| Net Cash Per Share | 282.37 |
| Equity (Book Value) | 4.54B |
| Book Value Per Share | 812.94 |
| Working Capital | 3.76B |
Cash Flow
In the last 12 months, operating cash flow was -823.92 million and capital expenditures -44.14 million, giving a free cash flow of -868.06 million.
| Operating Cash Flow | -823.92M |
| Capital Expenditures | -44.14M |
| Free Cash Flow | -868.06M |
| FCF Per Share | -70.50 |
Margins
Gross margin is 56.69%, with operating and profit margins of 16.09% and 64.22%.
| Gross Margin | 56.69% |
| Operating Margin | 16.09% |
| Pretax Margin | 69.28% |
| Profit Margin | 64.22% |
| EBITDA Margin | 18.61% |
| EBIT Margin | 16.09% |
| FCF Margin | -39.99% |
Dividends & Yields
This stock pays an annual dividend of 75.00, which amounts to a dividend yield of 1.07%.
| Dividend Per Share | 75.00 |
| Dividend Yield | 1.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 13.36% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.07% |
| Earnings Yield | 3.57% |
| FCF Yield | -1.01% |
Stock Splits
The last stock split was on January 7, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | Jan 7, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SunBio,Inc. has an Altman Z-Score of 2.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.31 |
| Piotroski F-Score | n/a |